Finance

Lists
IBIO:NASDAQ
Ibio Inc
$1.30
+1.17%
(+0.015) 1D
Sep 21, 10:53:07 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBIO...
Open
$1.29
High
$1.30
Low
$1.28
Mkt. cap
83.28M
Avg. vol.
692.18K
Volume
121.90K
52-wk high
$3.82
52-wk low
$0.77
EPS
-$0.32
Beta
1.29
Shares outstanding
64.31M
No. of employees
23
Open
$1.29
High
$1.30
Low
$1.28
Mkt. cap
83.28M
Avg. vol.
692.18K
Volume
121.90K
52-wk high
$3.82
52-wk low
$0.77
EPS
-$0.32
Beta
1.29
Shares outstanding
64.31M
No. of employees
23
News stories
From web sources and news partners
About Ibio Inc
CEO-
Employees23
Founded2008
Headquarters-
SectorBiotechnology
Websiteibioinc.com
Analyst ratings
Based on 4 analysts giving stock ratings to IBIO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IBIO in the last 3 months.
Highest
Current $1.30
$7.00 (+440.54%)
Average
$5.75 (+344.02%)
Lowest
$5.00 (+286.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Initiated
$7.00
+440.5%
09/17/2026
William Wood
B. Riley Securities
Buy
Initiated
$6.00
+363.3%
08/31/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$5.00
+286.1%
08/28/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$5.00
+286.1%
07/01/2026
Martin Auster
Raymond James
Buy
Initiated
$5.00
+286.1%
06/08/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
$6.00
+363.3%
05/15/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$6.00
+363.3%
05/14/2026
Catherine Novack
JonesTrading
Buy
Maintained
$7.00
+440.5%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
100.00K
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.55M
4.28M
3.25M
8.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50M
5.16M
5.11M
-2.18M
Operating expense
6.05M
9.44M
8.36M
6.38M
Total operating expenses
6.05M
9.44M
8.36M
6.38M
Operating income
-5.95M
-9.44M
-8.36M
-6.38M
Other non operating income
-
-
-
-
EBT including unusual items
-5.72M
-8.99M
-7.73M
-10.60M
EBT excluding unusual items
-5.72M
-8.99M
-7.73M
-5.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.72M
-8.99M
-7.73M
-10.60M
Net profit margin
-5,720.00%
-
-
-
Earnings per share
-0.11
-0.09
-0.06
-0.07
Interest and investment income
267.00K
493.00K
657.00K
779.00K
Interest expense
-36.00K
-41.00K
-22.00K
-
Net interest expenses
231.00K
452.00K
635.00K
779.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.76M
-9.30M
-8.21M
-6.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps